AbiliTech Medical is building a suite of orthotic devices to support and assist the arms in functional tasks required for independence in daily lives. The AbiliTech Assist will receive FDA clearance in 2020, followed by a hand device in 2022, and entrance into the Stroke Rehabilitation market in 2023. The total market opportunity this year is greater than $2 billion and grows to $37 billion over three years, with gross margins up to 75%.